BRKR
Get informed when a big investor buys or sells
+ FollowOvervalued by 81.1% based on the discounted cash flow analysis.
| Market cap | $8.78 Billion |
|---|---|
| Enterprise Value | $10.96 Billion |
| Dividend Yield | $0.20 (0.35%) |
| Earnings per Share | $-0.15 |
| Beta | 1.28 |
| Outstanding Shares | 152,200,000 |
| P/E Ratio | -82.55 |
|---|---|
| PEG | 10.53 |
| Price to Sales | 2.63 |
| Price to Book Ratio | 3.86 |
| Enterprise Value to Revenue | 3.13 |
| Enterprise Value to EBIT | 447.3 |
| Enterprise Value to Net Income | -154 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 0.98 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1579▼ 61.97% |
|---|---|
| Total Calls | 5,700▼ 97.37% |
| Total Puts | 900▼ 99.47% |
Holdings and activity of institutional investors.
| Ownership % | 21.75%▼ 68.44% |
|---|---|
| Total Invested | $1.95B▼ 60.57% |
| Investors Holding | 181▼ 169.00% |
No data
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...